comparemela.com

Latest Breaking News On - Wenbin li - Page 3 : comparemela.com

Nanotechnology Now - Press Release: Solvent study solves solar cell durability puzzle: Rice-led project could make perovskite cells ready for prime time

Nanotechnology Now - Press Release: Solvent study solves solar cell durability puzzle: Rice-led project could make perovskite cells ready for prime time
nanotech-now.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nanotech-now.com Daily Mail and Mail on Sunday newspapers.

Prescribed opioid analgesics in early pregnancy and the risk of congenital anomalies: a population-based cohort study

Background: Recent data suggest an increased risk of congenital anomalies with prenatal exposure to opioid analgesics. We sought to further quantify the risk of anomalies after opioid analgesic exposure during the first trimester in a population-based cohort study. Methods: Using administrative health data from Ontario, we followed 599 579 gestational parent–infant pairs from singleton pregnancies without opioid use disorder. We identified opioid analgesics dispensed in the first trimester and congenital anomalies diagnosed during the first year of life. We estimated propensity score–adjusted risk ratios (RRs) between first trimester exposure (any opioid analgesic and specific agents) and congenital anomalies (any anomaly, organ system anomalies, major or minor anomalies and specific anomalies). Results: The prevalence of congenital anomalies was 2.8% in exposed infants and 2.0% in unexposed infants. Relative to unexposed infants, we observed elevated risks among those who were e

Ascletis Announces First Patient Dosed in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.